People who miss appointments or stop taking their treatment often report being treated badly by healthcare workers when they return to health facilities. This fear of being reprimanded discourages people from going back to the clinic to seek support and receive their treatment, argues Bellinda Setshogelo and Sibongile Tshabalala.
A study recently published in The Lancet found that women living with HIV made up an astonishing 63.4% of new cervical cancer cases in South Africa in 2018. Elri Voigt spoke to local experts about the links between HIV and cervical cancer in South Africa and how cervical cancer is prevented, tested for, and treated in the public sector.
One of the biggest challenges now facing South Africa’s HIV response is how to support many more people living with HIV to engage or re-engage and then stay on treatment. One way to make it easier for people living with HIV to adhere to treatment is to provide a longer supply of medicines, argues Ndivhuwo Rambau & Simphiwe Xaba.
We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.
While South Africa is doing well on some of the UNAIDS HIV targets for 2020, one target we are set to miss is ensuring that 90% of people diagnosed with HIV are on antiretroviral therapy. Partly in response to this problem, the ‘Welcome back’ campaign started by Doctors without Borders aims to make it easier for people who have stopped taking treatment to restart. Tiyese Jeranji reports.
HIV medicines for children often taste bitter, pills are large, and for many children there is a lot of medication to take. This makes it hard to take treatment as prescribed. Tiyese Jeranji looks at the challenges with currently available HIV medicines for children, what innovations are in the pipeline, and how HIV treatment is being tailored to suit the needs of children.
While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.
Medicine stockouts can have dire consequences. Tendai Mafuma and Ruth Dube look at lessons learnt over the years on how to help prevent medicine stockouts and argue that although the interventions are not new, if implemented it could help solve the vicious cycle of medicine stockouts in the Eastern Cape.
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.
The Department of International Relations and Cooperation is investigating allegations that South Africans working at the Libyan embassy in Pretoria were pressured to test and reveal their HIV status after asking to be tested for COVID-19.